State transitions in uncomplicated pregnancies after term

J G Nijhuis1, M van de Pas, H W Jongsma

  • 1University Hospital St. Radboud, Department of Obstetrics/Gynaecology, Nijmegen, The Netherlands. J.Nijhuis@obgyn.azn.nl

Early Human Development
|October 23, 1998
PubMed

A behavioural state transition is the time interval between two different behavioural states. In low-risk fetuses, the fetal heart rate pattern (FHRP) is the first variable to change in transitions from 1F to 2F ('non-REM-sleep' to 'REM-sleep') and the last variable to change in transitions from 2F to 1F. This is not the case in IUGR (intra-uterine growth retardation), and absence of a specific order in which behavioural variables are changing might be an indication for a (mild) disturbance of the fetal central nervous system (CNS). We investigated whether state transitions in twelve low risk term fetuses (39-41 weeks post menstrual age, PMA; control group) differ from those in twelve uncomplicated pregnancies > 41 weeks PMA (study group). All subjects underwent one behavioural study in which fetal heart rate pattern, eye and body movements were recorded simultaneously. We recorded 23 transitions from 1F to 2F and 20 from 2F to 1F. Median (range) duration for transitions from 1F to 2F was 85 (10-180) s in the study group, and 60 (10-180) s in the control group. Transitions from 2F to 1F lasted 80 (10-140) and 60 (30-100) s, respectively. In both groups, the FHRP was the first variable to change in transitions from 1F to 2F, however, in transitions from 2F to 1F, no specific order in change of variables could be demonstrated. We conclude that the study of transitions does not distinguish between the term and after term fetuses under optimal conditions. Whether or not the analysis of state transitions can be used to distinguish 'normal' from 'abnormal' fetuses and detect the fetus at risk after term awaits further study.

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...